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Atomic force microscopyInsect immune response relies on the humoral and cellular mechanisms of innate immunity. The key factors
are the antimicrobial polypeptides that act in concert against invading pathogens. Several such components,
e.g. apolipophorin III (apoLp-III), lysozyme, and anionic peptide 2, are present constitutively in the hemo-
lymph of non-challenged Galleria mellonella larvae. In the present study, we demonstrate an evidence for a
synergistic action of G. mellonella lysozyme and apoLp-III against Gram-negative bacteria, providing novel
insights into the mode of action of these proteins in insect antimicrobial defense. It was found that the
muramidase activity of G. mellonella lysozyme considerably increased in the presence of apoLp-III. Moreover,
apoLp-III enhanced the permeabilizing activity of lysozyme toward Escherichia coli cells. As shown using
non-denaturing PAGE, the proteins did not form intermolecular complexes in vivo and in vitro, indicating
that the effect observed was not connected with the intermolecular interactions between the proteins. Anal-
ysis of AFM images of E. coli cells exposed to G. mellonella lysozyme and/or apoLp-III revealed evident alter-
ations in the bacterial surface structure accompanied by the changes in their biophysical properties. The
bacterial cells demonstrated signiﬁcant differences in elasticity, reﬂected by Young's modulus, as well as in
adhesive forces and roughness values in comparison to the control ones. The constitutive presence of these
two defense molecules in G. mellonella hemolymph and the fact that apoLp-III enhances lysozyme
muramidase and perforating activities indicate that they can be regarded as important antibacterial factors
acting at the early stage of infection against Gram-negative as well as Gram-positive bacteria.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Insect immune response relies on the humoral and cellular mech-
anisms of innate immunity. The key factors in ﬁghting against invad-
ing pathogens are the defense peptides and proteins synthesized
mainly in the fat body (functional analog of the mammalian liver)
and released into the hemolymph (insect blood). Recognition of
pathogens inside the insect hemocoel leads to rapid induction of
antimicrobial peptide synthesis and a considerable increase in their
concentration in the hemolymph. However, the hemolymph of
naive individuals exhibits a certain level of peptides and proteins
with antimicrobial activity, which are most probably involved in
the early steps of ﬁghting infection [1–6]. Several such components,
e.g. apolipophorin III (apoLp-III), lysozyme, anionic peptide 2,
and cecropin D-like peptide were detected in the hemolymph ofiology, Institute of Biology and
demicka St. 19, 20-033 Lublin,
1.
ytryńska).
rights reserved.non-challenged larvae of a lepidopteran insect, the greater wax
moth Galleria mellonella [7, 8].
Apolipophorin III (apoLp-III) is a well-known abundant hemolymph
protein functioning in the lipid transport and immune response in in-
sects. ApoLp-III is involved in the recognition of pathogens as it binds
components of bacterial and fungal cell walls, e.g. lipopolysaccharide,
lipoteichoic acids, and β-1,3-glucan. In addition, the protein is engaged
in the detoxiﬁcation of microbial cell envelope components. Participa-
tion of apoLp-III in the signaling network between hemolymph, hemo-
cytes, and fat body cells has also been postulated [9–17]. Recently,
apoLp-III antimicrobial activity against selected Gram-positive and
Gram-negative bacteria has been demonstrated [18, 19].
Similar to most insect lysozymes, G. mellonella lysozyme belongs
to a c-type lysozyme family [20–22]. The activity of lysozyme against
Gram-positive bacteria based on its muramidase enzymatic activity is
well documented [21, 23]. However, a relatively low lysozyme activ-
ity against Gram-negative bacteria was also demonstrated [22]. This
activity can be attributed to the non-enzymatic action of lysozyme
related to the cationic properties of the protein molecule or to its
particular cationic peptide fragments [24, 25].
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Escherichia coli became more sensitive to defense peptides such as
attacins, cecropins, and insect defensins [26, 27]. It was also suggested
that EWL could act synergisticallywith certainG.mellonella antimicrobi-
al peptides and proteins against Gram-negative bacteria in vitro [28].
Halwani and Dunphy [29] demonstrated an increase in EWL activity
against Micrococcus luteus in the presence of apoLp-III; however,
the mechanism of the synergistic action of these compounds was not
explained.
It is generally believed that antimicrobial peptides and proteins
present simultaneously in the insect hemolymph act in concert
against invading pathogens. Recently, results conﬁrming this state-
ment have been obtained in our laboratory. It has been found that
the activity of G. mellonella lysozyme against Gram-negative bacteria
considerably increased in the presence of Gm anionic peptide 2,
suggesting a synergistic antimicrobial action of these two defense fac-
tors [30]. Since the muramidase activity of G. mellonella lysozyme was
not affected in the presence of anionic peptide 2, the peptide most
probably enhanced the non-enzymatic mode of lysozyme action. In
addition to these two defense compounds, also apoLp-III occurs con-
stitutively in the G. mellonella hemolymph. Taking this into account,
research on the impact of apoLp-III on the antibacterial activity of
G. mellonella lysozyme has been undertaken. In the present study,
we demonstrate an evidence and an explanation for the synergistic
action of G. mellonella lysozyme and apoLp-III against Gram-negative
bacteria. Moreover, our results provide novel insights into the mode
of action of both these proteins in insect antimicrobial defense.2. Materials and methods
2.1. Bacterial strains and culture conditions
Gram-positive M. luteus ATCC 10240 and Gram-negative bacteria
E. coli D31 and JM83 were grown at 28 °C and 37 °C, respectively, in
2.5% Luria–Bertani (LB) medium. Bacteria in the logarithmic phase
of growth were used during the experiments.2.2. Insect immune challenge, hemolymph collection, and puriﬁcation of
G. mellonella lysozyme and apolipophorin III
The larvae of G. mellonella (Lepidoptera: Pyralidae) were reared on
honeybee nest debris (a natural diet). The hemolymph was collected
24 h after immunization of the larvae with live E. coli D31 andM. luteus
and then methanolic extracts were prepared from the hemocyte-free
hemolymph as described earlier [30, 31].
For the puriﬁcation of G. mellonella lysozyme and apoLp-III,
the hemolymph extract dissolved in 0.1% triﬂuoroacetic acid (TFA)
was subjected to HPLC using a Discovery Bio Wide Pore C18
4.6 mm×250 mm column (Sigma-Aldrich, USA) and two buffer
sets: A: 0.1% TFA (v/v), and B: 0.07% TFA, 80% acetonitrile (v/v).
A 1 ml/min ﬂow rate and a linear gradient from 30 to 70% of buffer
B were applied over 35 min. The homogenous fraction containing
apoLp-III eluted as a broad main peak at ca. 31–33 min. The fraction
containing lysozyme eluting at 15 min was collected, freeze-dried,
redissolved in 0.1% TFA, and additionally puriﬁed on the same
column and a buffer set as above, using a linear gradient from 37 to
42% B over 15 min. The homogenous peak of lysozyme eluted at
12 min. The fractions containing proteins were freeze-dried and stored
at −80 °C until use. The quantity of apoLp-III was determined by
weighing the freeze-dried protein powder while the concentration of
lysozyme in the solution was determined by amino acid analysis [32].
The homogeneity and identity of both proteins were conﬁrmed by
SDS-PAGE electrophoresis [33] and by N-terminal sequencing on an
automatic protein sequencer (Procise 491, Applied Biosystems).2.3. Interaction between molecules of G. mellonella lysozyme and apoLp-III
To elucidate the formation of a possible intermolecular com-
plex in vivo, non-immune and immune hemolymph samples
(50 μg of total protein) were resolved in non-denaturing condi-
tions [34] and electrotransferred onto PVDF membranes; the
membranes were probed with antibodies against G. mellonella
apoLp-III or against G. mellonella lysozyme (see below).
For testing the formation of the complex in vitro, the solutions of
puriﬁed lysozyme and apoLp-III in 20 mM sodium phosphate pH 6.8
were mixed together at 1:1 or 1:10 molar proportions. After incuba-
tion for 1 h at 28 °C or 37 °C, an appropriate volume of a sample
buffer (50% glycerol; 0.2% methyl green) was added, and the mixtures
were then analyzed by PAGE in non-denaturing conditions [34].
2.4. Immunoblotting
The protein samples subjected to non-denaturing PAGE were
transferred onto PVDF membranes (Millipore) as described previ-
ously [30]. For lysozyme and apoLp-III detection, the membranes
were probed with rabbit polyclonal antibodies to G. mellonella lyso-
zyme (1:1000) and to G. mellonella apoLp-III (1:2500), respectively.
Alkaline phosphatase-conjugated goat anti-rabbit IgG (1:30000)
was used as a second antibody. Anti-G. mellonella lysozyme antibod-
ies were kindly provided by Prof. I.H. Lee (Department of Life Science,
Hoseo University, South Korea). Anti-G. mellonella apoLp-III antibodies
were custom ordered in Agrisera (Sweden).
2.5. Antibacterial activity of G. mellonella lysozyme
2.5.1. Muramidase activity
The enzymatic activity of lysozyme was determined by measuring
the decrease in the optical density of the lyophilizedM. luteus suspen-
sion at 450 nm (0.2 mg/ml in 150 mM phosphate buffer pH 6.4)
during incubation with lysozyme (0.015 μM), apoLp-III as well as
the mixtures of both compounds. Prior to incubation, lysozyme,
apoLp-III, and the combinations of lysozyme with apoLp-III were pre-
pared in 20 mM phosphate buffer pH 6.8 (ﬁnal volume 30 μl) in the
wells of a 96-well polypropylene plate. The ﬁnal molar ratios of lyso-
zyme and apoLp-III were 1:0, 1:0.1, 1:0.2, 1:1, 1:5, 1:10, 1:25, and 0:1.
After 15 min preincubation at 28 °C, 100 μl of M. luteus suspension
was added to the mixtures and the plate was incubated for 3 h at
28 °C with shaking. The optical density of the suspensions was mea-
sured every 30 min at 450 nm.
2.5.2. Bacterial membrane permeabilization assay
The membrane perforation ability of lysozyme and apoLp-III was
determined by a colorimetric method using an E. coli JM83 strain
containing plasmid pCH110 (Pharmacia-Amersham, Piscatway, NJ,
USA). The plasmid encodes ampicillin resistance and constitutively
synthesized cytoplasmic β-galactosidase [35]. The conditions of the
assay were described in detail in our previous paper [30]. Brieﬂy,
after preincubation of G. mellonella lysozyme, apoLp-III, and the
mixtures of both compounds in 20 mM phosphate buffer pH 6.8,
a suspension containing live mid-logarithmic-phase bacterial cells
(5×105 CFU) was added and the samples were incubated for 45 min
at 37 °C (the ﬁnal concentrations of the proteins studied were 0.5 μM
and 5 μM). Then, a β-galactosidase colorimetric substrate was added
and, after an additional 90 min of incubation at 37 °C, absorbance was
measured at 405 nm. All the assays were performed in triplicate.
2.6. AFM imaging of bacterial cells
Preparation of bacterial samples and the conditions of cell imaging
by AFM were described in detail in our previous paper [30]. Brieﬂy,
log-phase E. coli JM83 cells were incubated for 1.5 h without (control)
Fig. 1. The effect of apolipophorin III on the muramidase activity of G. mellonella lyso-
zyme. The suspension of lyophilized M. luteus was incubated without (control) and in
the presence of lysozyme (0.015 μM) or apoLp-III or with both compounds at the indi-
cated molar ratios (lysozyme:apoLp-III) as described in Materials and methods. The ab-
sorbance at 450 nm was measured every 30 min during a period of 3 h. The diagram
shows representative results obtained after 1 h incubation. The optical density of the
bacterial suspension incubated without any addition was assumed as 100%. The data
are presented as ±SD of three independent experiments. Statistical signiﬁcance in
comparison to optical density of the bacterial suspension treated with lysozyme:
**pb0.01; ***p≤0.001.
Fig. 2. The effect of apolipophorin III on the bacterial membrane permeabilizing activity of
G. mellonella lysozyme. E. coli JM83 cells were incubated without (control) and in the
presence of lysozyme or apoLp-III (0.5 μM and 5 μM) or both compounds as described
in Materials and methods. Then β-galactosidase substrate was added and the absorbance
wasmeasured at 405 nm. The perforation level of the dead bacteriawas assumed as 100%.
The data are presented as ±SD of three independent experiments.
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both compounds (ﬁnal concentrations of 0.5 μM and 5 μM) at 28 °C.
After the treatment, the bacteria were suspended in apyrogenic
water (5 μl); the samples were applied on the surface of mica disks
and allowed to dry overnight at 28 °C before imaging.
AFM imaging of the bacterial cellswas carried out using aNanoScope
V AFM equipped with NanoScope 8.10 software (Veeco, USA). Three
ﬁelds were imaged on each mica disk. WSxM 5.0 software (Nanotec,
Spain) was used for the analysis of the obtained data. The roughness
values were measured on 600×600 nm areas of the entire bacterial
cells. For the calculation of the average surface root-mean-square
(RMS) roughness, forty ﬁelds from two independent experiments
were estimated. The elasticity and adhesion properties of the bacterial
cells were analyzed with NanoScope Analysis ver. 1.40 software, after
forcemeasurements had been performed in the “PeakForceQNM” oper-
ation mode using a silicon tip SCANASYST-AIR with a spring constant of
0.4 N/m (Veeco, USA).
2.7. Other methods
The protein concentration in the hemolymph and methanolic
extracts was estimated by the Bradford method using BSA as a
standard [36].
The data are presented as means±standard deviation (SD) of at
least three experiments. In order to compare two means, statistical
analysis was performed by the Student's t-test.
3. Results
3.1. The effect of apoLp-III on the level of lysozyme enzymatic activity
The inﬂuence of apoLp-III on the lysozyme muramidase activity
was examined using a suspension containing M. luteus cell wall com-
ponents as a substrate for lysozyme. The suspension was incubated in
the presence of lysozyme or apoLp-III or a mixture of both proteins
in different molar ratios, including 1:5, 1:10, and 1:25 (lysozyme:
apoLp-III). One-hour incubation with lysozyme (0.015 μM) decreased
the optical density of the suspension by ca. 42%, whereas the presence
of apoLp-III did not affect its optical density at all the concentrations
used (Fig. 1). However, when the M. luteus suspension was treated
with the mixtures of both compounds, further reduction of the optical
density was noticed. At the molar ratios 1:10 and 1:25, the decreases
were calculated as ca. 58% and 61%, respectively (Fig. 1). The results
obtained suggest that the muramidase activity of G. mellonella lyso-
zyme is considerably increased in the presence of apoLp-III.
3.2. The effect of apoLp-III on the level of E. coli perforation by lysozyme
As it was demonstrated in our previous paper, G. mellonella
lysozyme exhibited a bacterial membrane permeabilization activity
when tested against E. coli JM83 cells [30]. We were interested in
whether the increased muramidase activity of lysozyme detected
in the presence of apoLp-III could enhance the above-mentioned ly-
sozyme permeabilizing activity. ApoLp-III used alone at the concen-
tration range of 0.5–5 μM (up to 50 μM) did not perforate E. coli
cells. However, it increased signiﬁcantly the perforating activity of
G. mellonella lysozyme (Fig. 2). Lysozyme used alone at the concen-
trations of 0.5 μM and 5 μM perforated bacterial cells in ca. 10%
and 44%, respectively. When the bacteria were incubated in the pres-
ence of 0.5 μM lysozyme, the addition of apoLp-III at the concentra-
tions of 0.5 μM and 5 μM caused two- and three-fold increases
in the lysozyme permeabilizing activity, respectively. Treatment of
the bacteria with both compounds used at the concentration of
5 μM led to an increase in bacterial membrane perforation from
ca. 44% to 60% (Fig. 2). The results presented indicate clearly thatthe perforation activity of G. mellonella lysozyme is enhanced by
apoLp-III.
3.3. AFM analysis of E. coli cell surface alterations caused by lysozyme
and apoLp-III
E. coli JM83 cells treated with G. mellonella lysozyme or/and
apoLp-III were analyzed by AFM. The analysis revealed that the incu-
bation of the bacterial cells in the presence of the insect defense
factors studied caused considerable alterations in the cell surface
(Figs. 3, 4). The evident changes in the surface structure were accom-
panied by the changes in the biophysical properties (Table 1). Despite
the fact that apoLp-III did not perforate E. coli cells, it induced alter-
ations in the bacterial cell surface and modiﬁed, to some extent, the
morphology of the bacteria. When the bacterial cells were treated
with apoLp-III used at a concentration of 0.5 μM, the cell surface be-
came rougher in comparison to the control cells (Fig. 3). The RMS
Fig. 3. AFM image of E. coli JM83 cell surface alterations after treatment with G. mellonella apolipophorin III. The bacteria were incubated without (control) or in the presence of
apoLp-III (0.5 μM) as described in Materials and methods; then, the microscopic analysis was performed. The deﬂection, 3D, and topography images are presented. The diagrams
show the section proﬁles corresponding to the green lines visible in the topography images.
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calculated as 7.653 nm (±2.71) and 11.564 nm (±4.92; p=0.01),
respectively. Upon treatment of E. coli with apoLp-III used at a
concentration of 5 μM, further cell surface alterations appeared
and some changes in the bacterial cell morphology were observed
(Fig. 4A). Some blurred cell contours were noticed especially at the
poles. Although the cells incubated in the presence of G. mellonella ly-
sozyme (0.5 μM) retained their shape, numerous cavities and altered
surface texture of the cells were detected. In addition, the ﬂagella,
well visible in the control cell images, were no longer noticed
(Fig. 4A). The E. coli cells treated with both compounds presented a
different picture. The cells were still rod-shaped, but their poles were
not round. They also exhibited a distinct surface texture (Fig. 4A). The
cells treated with each compound, however, especially those exposed
to lysozyme, were much higher than the control ones, probably indi-
cating swelling symptoms (Fig. 4B). The bacterial cells exposed to
G. mellonella lysozyme and/or apoLp-III demonstrated signiﬁcant dif-
ferences in elasticity, reﬂected by Young's modulus, as well as in adhe-
sive forces and roughness values in comparison to the control ones
(Table 1). Treatment of E. coli with lysozyme or apoLp-III alone led to
a signiﬁcant, ca. 2.7–3.1 fold, decrease in the bacterial cell surface elas-
ticity, whichwas accompanied by a ca. 1.8–2.3 fold increase in adhesive
forces to the AFM tip. In addition, an increase in the RMS roughness
values was detected. However, although the treatment of the bacteria
with apoLp-III or lysozyme alone induced apparent changes of all the
cell surface properties tested, only adhesion forcewas altered consider-
ably after exposing the bacteria to the mixture of both compounds. In
comparison to the control cells, a 2.9-fold increase in this parameter
value was noticed, indicating that the treatment of E. coli with both
compoundshad a stronger impact on adhesion forces than the exposure
to apoLp-III or lysozyme alone (Table 1).
3.4. Analysis of intermolecular complex formation between G. mellonella
lysozyme and apoLp-III
In order to provide more insight into the mode of the synergistic
action of the proteins studied, the possibility of intermolecular com-
plex formation between apoLp-III and lysozyme in vivo and in vitroFig. 4. AFM image of E. coli JM83 cell surface alterations after treatment with G. mellonella ly
presence of lysozyme (0.5 μM) or apoLp-III (5 μM) or both compounds as described in Mat
topography images, as well as the image of the adhesion analysis are presented. The whit
ellipses indicate the cavities and pole damages, respectively, appearing after the treatmen
of the cells treated with apoLp-III. The white squares mark the altered poles of the cells tr
section proﬁles corresponding to the green lines in the images are presented.was investigated. For evaluating whether the proteins form a com-
plex in vivo, the samples of G. mellonella non-immune and immune
hemolymphs collected at different time points after the challenge
were resolved in non-denaturing conditions and electrotransferred
onto PVDF membranes. Then the membranes were probed with anti-
bodies against G. mellonella apoLp-III and G. mellonella lysozyme.
Several bands reﬂecting apoLp-III were recognized by anti-apoLp-III
antibodies, suggesting formation of complexes with other hemolymph
proteins or the presence of apoLp-III isoforms in the hemolymph. The
multiple apoLp-III bands could also be explained by the occurrence of
the lipid-free and lipid-bound populations of this protein in G. mellonella
hemolymph. In contrast, only one band was recognized by anti-
lysozyme antibodies in all the hemolymph samples tested (Fig. 5). The
location of the apoLp-III and lysozyme bands on the membranes indi-
cated that the proteins did not form intermolecular complexes in vivo
in the hemolymph of the naive as well as immune-challenged insects.
These ﬁndings were conﬁrmed by in vitro experiments inwhich poten-
tial complex formation between puriﬁed apoLp-III and lysozyme was
investigated. Incubation of the proteins in different molar ratios at
two different temperatures (28 °C and 37 °C) did not lead to the forma-
tion of a complex as revealed by electrophoresis in non-denaturing con-
ditions (data not shown). All these results demonstrate clearly that the
observed apoLp-III-induced enhancement of the permeabilizing activity
of G. mellonella lysozyme was not connected with the intermolecular
interactions between the proteins.
4. Discussion
Binding of G. mellonella lysozyme and apoLp-III to the cell surface of
different Gram-positive and Gram-negative bacteria, including E. coli,
was demonstrated in our previous reports [18, 30]. In addition, the syn-
ergistic action of two constitutive components of G. mellonella hemo-
lymph, lysozyme and Gm anionic peptide 2, against Gram-negative
bacteria was documented [30]. The present study provides further
evidence on the synergistic action of G. mellonella lysozyme and
other hemolymph defense factors against this class of bacteria. The
permeabilizing activity of G. mellonella lysozyme toward E. coli cells
was signiﬁcantly enhanced in the presence of apoLp-III, which did notsozyme and apolipophorin III. The bacteria were incubated without (control) or in the
erials and methods; then, the microscopic analysis was performed. (A) 3D, height and
e arrows mark ﬂagella, well visible in the control images. The black arrows and black
t of cells with lysozyme. The white arrowheads indicate blurred contours at the poles
eated with lysozyme and apoLp-III. (B) The height images and diagrams showing the
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Table 1
The effect of G. mellonella lysozyme and apolipophorin III on the biophysical properties
of the E. coli JM83 cell surface.
Control Lysozyme
(0.5 μM)
apoLp-III
(5 μM)
Lysozyme+apoLp-III
(0.5 μM+5 μM)
Young's modulus
(GPa)
2.118
(±0.364)
0.681⁎⁎⁎
(±0.197)
0.796⁎⁎⁎
(±0.264)
1.856
(±1.158)
Adhesion force
(nN)
0.357
(±0.182)
0.813⁎⁎⁎
(±0.175)
0.634⁎⁎⁎
(±0.11)
1.053⁎⁎⁎
(±0.233)
RMS roughness
(nm)
7.653
(±2.71)
10.718⁎⁎⁎
(±4.524)
12.218⁎⁎⁎
(±5.29)
7.584
(±2.0)
The bacteriawere incubatedwithout (control) or in the presence of lysozyme, apoLp-III or
both compounds. Analysis of the biophysical properties of the bacterial cell surface was
performed using AFM. The data are presented as means±SD. Statistical signiﬁcance:
⁎⁎⁎p≤0.001.
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the possibility of complex formation between apoLp-III and lyso-
zyme molecules was evaluated. Our results demonstrated that the
proteins did not form intermolecular complexes either in vivo or in
vitro, as revealed by PAGE in non-denaturing conditions. Similar re-
sults were described by Halwani and Dunphy [29]; however, instead
of G. mellonella lysozyme, a commercial egg white lysozyme was
used in their study. Another explanation of the observed phenome-
non might be the induction of alterations in the bacterial cell surface
upon the binding of apoLp-III. The changes caused by apoLp-III in the
cell surface of different bacteria were described in our previous
paper [19]. Evidence supporting such prediction has been demon-
strated recently by Oztug et al. [17], who have reported the forma-
tion of stable complexes consisting of four G. mellonella apoLp-III
molecules and 24 molecules of E. coli LPS. Moreover, as found by
Zakarian et al. [37], the binding of G. mellonella apoLp-III increased
hydrophobicity as well as the negative charge of the bacterial cell
surface. Such alterations in the properties could enhance the interac-
tion of cationic lysozyme molecules with bacterial cell surface and
facilitate more effective peptidoglycan digestion, ﬁnally leading to
a cell death. The alterations in the biophysical properties of the bac-
terial cell surface detected by us using AFM analysis indicated that
the presence of both apoLp-III and lysozyme altered the surface char-
acteristics considerably. However, apparent changes in the proper-
ties analyzed, such as elasticity, adhesion forces, and roughness,
were detected in E. coli cells exposed to apoLp-III or lysozyme
alone. Although the treatment of the bacteria with a mixture of
both compounds led to a further increase in adhesion forces, surpris-
ingly, the other parameters were not altered in comparison to the
control cells. Logically thinking, one would expect that the increasedFig. 5. Analysis of complex formation betweenG.mellonella apolipophorin III and lysozyme
in vivo. The non-immune (NH) and immune hemolymph samples (50 μg of total protein)
collected at different time points after the challenge were resolved by PAGE in non-
denaturing conditions as described in Materials and methods. Then the proteins
were electrotransferred onto PVDF membranes and the membranes were probed
with antibodies against G. mellonella apoLp-III or G. mellonella lysozyme. The arrows
and the asterisk indicate several bands and a single protein band recognized by
anti-apoLp-III and anti-lysozyme antibodies, respectively.permeabilizing effect of the simultaneous action of both factors stud-
ied against E. coli should be reﬂected by considerable changes in the
parameters describing the biophysical properties of the surface of
the treated cells. However, since the Gram-negative bacterial cell enve-
lope is a complex structure consisting of the extracellular polymeric
substance (EPS) and outer membrane components, this relationship
may be much more complicated. The interactions of one compound
(e.g. apoLp-III) with the E. coli cell surface could certainly affect the
binding of the other one (e.g. lysozyme). In addition, this could provoke
unusual interactions between the cell envelope molecules. Moreover,
the biophysical properties of the cell surface of E. coli treated with
both apoLp-III and lysozyme could change continuously during the
treatment, however in a different manner and to a different extent
than while exposing the bacteria to a single defense protein. Therefore,
the ﬁnal effect, determined at a certain time point, might not be
reﬂected by the changes in each biophysical parameter of the surface.
Taking the above into consideration, G. mellonella apoLp-III seems
to potentiate the anti-E. coli activity of lysozyme in two steps. Initial
binding of apoLp-III to the bacterial cell surface (most probably to
LPS) alters cell surface texture and properties in a way that facilitates
and/or accelerates lysozyme binding to the bacteria. Simultaneous
binding of both proteins to the bacterial cell surface could also take
place. After the interaction of lysozyme with the altered cell surface,
apoLp-III, still surface-bound, enhances the muramidase activity of ly-
sozyme by a yet unexplained mechanism. In our study, G. mellonella
apoLp-III increased the muramidase activity in a standard assay, in
which dead M. luteus cells were used. This fact, together with the ob-
servation that apoLp-III and lysozyme do not form intermolecular
complexes, suggests that apoLp-III enables a more efﬁcient action of
lysozyme by inﬂuencing the properties of certain bacterial cell wall
components. Possibly, the changes caused by apoLp-III interaction
with the E. coli cell envelope are sufﬁcient to facilitate accessibility
of the peptidoglycan layer to the muramidase activity of lysozyme.
Considerably, the enhancing effect of apoLp-III on both perforating
and muramidase lysozyme activities was observed at the same
molar excess of apoLp-III (lysozyme:apoLp-III — 1:10), supporting
the idea that the apoLp-III-induced increment in the muramidase
activity could explain the enhanced perforating activity of lysozyme
toward E. coli. This is noticeable because the lysozyme concentration
in G. mellonella hemolymph is much lower in comparison to the
apoLp-III concentration. In the hemolymph of G. mellonella naive
larvae, this protein is present constitutively at a concentration of
ca. 0.76 μM (±0.17 μM); however, in bacteria-challenged insects a
ca. 10-fold increase in the lysozyme concentration was reported [8].
In contrast, the hemolymph titer of apoLp-III in G. mellonella larvae
was estimated at 0.7 mg/ml (ca. 40 μM) [38] and even 8.7 mg/ml
(ca. 480 μM) [29]. On the basis of our study, the concentration of
this protein in G. mellonella non-immune hemolymph was calculated
as ca. 350–400 μM (unpublished data). A simple mathematical calcu-
lation reveals at least 50-fold (or even 600-fold) molar excess of
apoLp-III in comparison to lysozyme in the hemolymph of the naive
larvae. However, one should keep in mind that apoLp-III exists in he-
molymph in a free and lipophorin-bound form [13]. Interaction with
lipophorin particles decreases the concentration of free apoLp-III,
which would bind to a bacterial cell surface and act synergistically
with other defense factors.
It can be postulated that apoLp-III plays an analogous role in an insect
immune response to that played by bactericidal/permeability-increasing
protein (BPI) in a mammalian innate immunity. BPI is a 55 kDa cationic
antimicrobial polypeptide exhibiting, likewise apoLp-III, high afﬁnity to
the lipid A region common to all LPS of Gram-negative bacteria. After
binding to LPS in the bacterial outermembrane, BPImolecules penetrate
the bacterial inner membrane, which leads to the loss of membrane in-
tegrity, electrochemical gradient impairment, and death of the bacteri-
um [39]. Moreover, the BPI's antibacterial activity is synergistically
enhanced by defense peptides, such as defensins and cathelicidins [40].
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G. mellonella lysozyme and anionic peptide 2 against E. coli led to the
formation of sodium chloride crystals suggesting the destabilization
of the osmotic balance of the bacteria [30], no crystals were detected
after the treatment of E. coliwith a mixture of lysozyme and apoLp-III.
Moreover, anionic peptide 2 enhanced the antibacterial activity of
G. mellonella lysozyme without affecting its enzymatic activity [30].
In contrast, as presented in this study, apoLp-III increased the
muramidase activity of G. mellonella lysozyme. These ﬁndings clearly
indicate a distinct mode of the synergistic antibacterial action of
apoLp-III and anionic peptide 2 with lysozyme in G. mellonella hemo-
lymph. Our results suggest that the effect of the action of G. mellonella
lysozyme against Gram-negative bacteria could be ampliﬁed through
increasing its enzymatic and non-enzymatic activities by apoLp-III
and anionic peptide 2, respectively.
As demonstrated previously, the growth of E. coli was not inhibited
by G. mellonella apoLp-III, whereas other Gram-negative bacteria, such
as Salmonella Typhimurium and Klebsiella pneumoniae, were highly sen-
sitive to apoLp-III action [18]. The causes of the different antibacterial
activity of apoLp-III remain unclear. During binding to LPS, apoLp-III in-
teracts with lipid A as well as a carbohydrate core of the LPS molecule
[16]. Since lipid A represents the least heterogeneous region of the LPS
molecule [41, 42], the differences in the apoLp-III activity toward
Gram-negative bacteria could be related to the differences in the
structure and composition of the carbohydrate core regions. However,
irrespective of this, it is possible that an effective ﬁght against particular
bacteria, e.g. E. coli, requires cooperation between certain G. mellonella
hemolymph defense factors. So far, the results of our research on
G. mellonella antimicrobial peptides and proteins provided two
examples of such cooperation: lysozyme with anionic peptide 2
and lysozyme with apoLp-III. Taking into consideration the constitu-
tive presence of these three defensemolecules in G. mellonella hemo-
lymph and the fact that apoLp-III enhances lysozyme muramidase
activity, they can be assumed as important antibacterial factors
acting at the early stage of infection with Gram-negative as well as
Gram-positive bacteria.
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